The Role of Gut Microbiota in High-Fat-Diet-Induced Diabetes: Lessons from Animal Models and Humans.
Study Goal
The researchers aimed to explore the relationship between dietary fat, diabetes, and gut microbiome composition, focusing on how gut microbiota dysbiosis may influence insulin resistance.
Results Summary
The study found that gut microbiota dysbiosis, particularly involving butyrate-producing bacteria, is linked to insulin resistance in diabetes, suggesting potential benefits from probiotic and prebiotic interventions. However, detailed mechanisms and specific dietary factors remain unclear.
Population
Preclinical animal models and human patients with diabetes compared to healthy controls.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
diet and nutrition | neutral | development of diabetes mellitus | - | - | play a significant role | #1 |
intestinal microbiota | neutral | progression and prevention of insulin resistance | diabetes | - | becoming abundantly apparent | #2 |
gut microbiota composition | neutral | butyrate-producing bacteria | preclinical animal models and human patients | - | differences have been observed | #3 |
gut microbiota dysbiosis | decrease | intestinal barrier functions | - | - | may disrupt | #4 |
gut microbiota dysbiosis | neutral | host metabolic pathways | - | - | may alter | #5 |
probiotic and prebiotic approaches | neutral | diabetes | - | - | promising | #6 |
probiotic and prebiotic approaches | increase | composition of the gut microbial community | - | - | favorably modifying | #7 |
The number of diabetes mellitus patients is increasing rapidly worldwide. Diet and nutrition are strongly believed to play a significant role in the development of diabetes mellitus. However, the specific dietary factors and detailed mechanisms of its development have not been clearly elucidated. Increasing evidence indicates the intestinal microbiota is becoming abundantly apparent in the progression and prevention of insulin resistance in diabetes. Differences in gut microbiota composition, particularly butyrate-producing bacteria, have been observed in preclinical animal models as well as human patients compared to healthy controls. Gut microbiota dysbiosis may disrupt intestinal barrier functions and alter host metabolic pathways, directly or indirectly relating to insulin resistance. In this article, we focus on dietary fat, diabetes, and gut microbiome characterization. The promising probiotic and prebiotic approaches to diabetes, by favorably modifying the composition of the gut microbial community, warrant further investigation through well-designed human clinical studies.